GE Healthcare

GE Healthcare


Sorry, your search for: did not find any results

Search Suggestions: Make sure your keyword(s) are spelled correctly Try another keyword(s) Try more general keyword(s)

European Multidisciplinary Cancer Congress 2011

September 26, 2011

GE Healthcare booth

GE Healthcare Spotlights its Commitment to Advancing Cancer Care at European Multidisciplinary Cancer Congress 2011 in Stockholm.

A key global healthcare challenge is the dramatic worldwide increase in cancer incidence. According to World Health Organization data, cancer rates could increase by 50 percent, leading to 15 million new cases in 2020. GE Healthcare, the health business of General Electric, showcased today its commitment to strengthening cancer diagnosis and care through its advanced cancer diagnostic and molecular imaging capabilities, as well as its technologies for the manufacture of biopharmaceuticals and for cancer research.

This press kit contains materials and images related to this announcement.

PRESS CONTACT: Allison Cohen, Corporate ( +972 547 299 742


“Over the last decade, technology innovations in radiation therapy have enabled more efficient treatments. The targeting precision of the latest linear accelerators require excellent imaging in order to create accurate treatment plans. Imaging technology therefore followed this evolution while workflow and access to planning tools and imaging information was not always optimal. With the MD Connect solution, GE Healthcare enables access to these oncology tools and clinical images anywhere in the oncology department, bringing patient information and oncology application tools directly to the physicist, medical oncologist and other oncology caregivers. Information regarding the patient’s treatment defined by each specialist is now available at anytime, anywhere, by anyone, enabling a better quality of treatment.”
Pascal Fenoglietto, Head of Research and Development and Head of Physics department at CRLC Val d'Aurelle in Montpellier, France.